Venture Capital Access Online | The eMarketplace for the Venture Capital Industry

 

Home

Marketplace
Database
News
Store
Resources
Contact Us

 

 

News


VENTURE CAPITAL DIRECTORY | PRIVATE EQUITY DIRECTORY

List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory

2021 NEW EDITION NOW AVAILABLE!
Buy Now for $119.95 with a free annual update in January 2022

Learn More or Buy Now

VCPro Database 2021 24th Edition -- a downloadable and searchable venture capital database with 6,500+ venture capital and private equity firms worldwide. The most reliable, up-to-date and affordable venture capital directory of its kind. VCPro Database is available in both Windows and macOS versions. It has been published since 1998. (Updated JULY 2021)

Learn More or Buy Now




Thrivable Raises $1.7M For Real-time Health Care Market Research

B2B SaaS firm connects companies with patients to create better health care products and services.

CLEVELAND, June 9, 2021-- Real-time market research platform Thrivable announced today that it has closed $1.7M in funding. With an ever-increasing roster of more than 40,000 patients at the ready, Thrivable allows health care companies to complete surveys, interviews, usability studies, and more in just days compared to the industry standard of weeks and even months.

"We know that in today's extremely competitive environment, the most patient-centric companies win," notes Thrivable CEO David Edelman. "It's why we enable on-demand access to quality panelists that companies need to make sure patient insights inform everyday decisions."

Thrivable's growing list of notable health care customers

Many of the world's largest medical technology companies are counted among Thrivable's growing list of customers who use the platform to ensure that the customer voice is a continuous driver of important business decisions. As John Mueckler, senior marketing research and analytics program manager at Medtronic, attests, "Having quick and easy access to our target audience has provided us a powerful tool for the business, allowing us to shorten the cycle for testing, making revisions, and re-testing."

Innovative medtech startups, such as Diabeloop and Tandem Diabetes Care, also turn to Thrivable to engage with patients as early as possible in the product design and development process. "Thrivable pairs precision-targeting with a platform that automates hundreds of critical steps to make the research process effortless. In this sense, we're democratizing access to patient insights for startups," states Edelman.

Local, regional, and national investors participate in the funding round

Investors in this round include Allos Ventures, JumpStart, North Coast Ventures, and Early Light Ventures. The investment will allow Thrivable to immediately expand its global team of full-time employees with a focus on the areas of technology, research, data science, sales, and marketing.

"We see Thrivable as the answer to the unique challenges health care market researchers face today getting the quality patient insights needed to be agile in an incredibly competitive market. We're excited to be a partner as Thrivable continues to innovate its platform and expand the health conditions that it serves," says Paul Ehlinger, principal at Allos Ventures.

Among the new members joining Thrivable's board of directors are Brad Owen, Alan Brenner, and Harris Drantch. Owen, who founded NeverBounce in 2014, served as vice president of product tools at ZoomInfo following its acquisition of NeverBounce. Brenner was previously a senior vice president of engineering at both Blackberry and Sun Microsystems. Currently a principal at Coppermine Capital LLC, Drantch previously held the roles of assistant vice president for private equity at Wafra Partners and investment banking analyst at Cain Brothers.

Also joining Thrivable in an advisory role are Royce Brunson, an operations executive who is the chief revenue officer at Health Recovery Solutions, and Michael Classen, an executive officer with Greenspring Associates.

About Thrivable

As the health care industry's first real-time market research platform, Thrivable is helping patients and companies create a better future together. The Thrivable rapid market research platform enables organizations to go from question to insight in hours with easy-to-use survey tools and an on-demand patient panel. Learn more: thrivable.app.

About Allos Ventures

Allos Ventures invests in early-stage technology companies based in the Midwest. Investments focus on B2B software companies at a Series A or B stage, augmenting the capital provided by seed and startup investors. In addition to the capital Allos provides, portfolio companies benefit from the extensive operating and business-building experience of the firm's managing partners, who make themselves available as needed to support each portfolio company's growth.

About JumpStart

JumpStart is a nationally recognized investing, entrepreneurial support, and economic development organization dedicated to unlocking entrepreneurship to transform entire communities.

About North Coast Ventures

North Coast Ventures is a contributed capital and "sidecar" pre-seed investment fund with a focus on early-stage technology investments. Membership consists of over 180 of the region's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.

About Early Light Ventures

Early Light Ventures focuses on providing funding for first-time founders with "need-to-have" B2B software products that have seen the opportunities in their industry firsthand.


News Index

Venture Capital Database 

 

 NEWS

Latest VC News
VC News Archive
News Search
RSS News Feed

List Your Firm

Entrepreneurs
Investors
Advisors

Venture Capital Database

VCPro Database
Download Trial
Buy Now

Business Plan Tools

Free Business Plan Template

 

Copyright 1998-2021 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer